| Product NDC: | 43063-386 |
| Proprietary Name: | Hydrocortisone |
| Non Proprietary Name: | Hydrocortisone |
| Active Ingredient(s): | 20 mg/1 & nbsp; Hydrocortisone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43063-386 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA083365 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19730618 |
| Package NDC: | 43063-386-30 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (43063-386-30) |
| NDC Code | 43063-386-30 |
| Proprietary Name | Hydrocortisone |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (43063-386-30) |
| Product NDC | 43063-386 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hydrocortisone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19730618 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | HYDROCORTISONE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |